Werbung
Deutsche Märkte geschlossen
  • DAX

    17.917,28
    -171,42 (-0,95%)
     
  • Euro Stoxx 50

    4.939,01
    -50,87 (-1,02%)
     
  • Dow Jones 30

    38.051,78
    -409,14 (-1,06%)
     
  • Gold

    2.341,60
    +3,20 (+0,14%)
     
  • EUR/USD

    1,0739
    +0,0038 (+0,35%)
     
  • Bitcoin EUR

    60.006,21
    -539,39 (-0,89%)
     
  • CMC Crypto 200

    1.392,62
    +10,05 (+0,73%)
     
  • Öl (Brent)

    82,80
    -0,01 (-0,01%)
     
  • MDAX

    26.043,18
    -302,89 (-1,15%)
     
  • TecDAX

    3.266,76
    -32,84 (-1,00%)
     
  • SDAX

    13.995,77
    -211,86 (-1,49%)
     
  • Nikkei 225

    37.628,48
    -831,60 (-2,16%)
     
  • FTSE 100

    8.078,86
    +38,48 (+0,48%)
     
  • CAC 40

    8.016,65
    -75,21 (-0,93%)
     
  • Nasdaq Compositive

    15.563,22
    -149,53 (-0,95%)
     

Carl Icahn has reportedly taken a stake in Bristol-Myers and its shares are jumping

carl icahn
carl icahn

(Brendan McDermid/Reuters)

Billionaire Carl Icahn has taken a stake in the pharmaceutical company Bristol-Myers and sees it as a possible takeover target, according to The Wall Street Journal.

Bristol-Myers shares gained as much as 5% in late trading on Tuesday after the news crossed.

Bristol-Myers announced earlier Tuesday an expanded share-buyback program, and named three new board members, following pressure from activist investor Jana Partners. The companies had been in talks since Jana Partners became a shareholder in the fourth quarter, Bristol-Myers said.

Icahn sees value in the company's pipeline of drugs which currently includes treatments for heart diseases and cancer, the report said.

Screen Shot 2017 02 21 at 3.47.30 PM
Screen Shot 2017 02 21 at 3.47.30 PM

(Markets Insider)

WERBUNG

NOW WATCH: 1,500 happily-married people say the key to lasting relationships isn’t communication — it’s respect



More From Business Insider